SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 406 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,459,560 | +109.4% | 16,050 | -51.0% | 6.34% | +90.5% |
| Q1 2023 | $4,516,689 | -48.4% | 32,770 | -51.5% | 3.33% | -38.2% |
| Q4 2022 | $8,746,650 | +90.7% | 67,500 | +62.7% | 5.38% | +172.6% |
| Q3 2022 | $4,587,000 | -42.2% | 41,500 | -30.8% | 1.98% | +39.9% |
| Q2 2018 | $7,931,000 | +478.1% | 60,000 | +20.0% | 1.41% | +176.9% |
| Q4 2016 | $1,372,000 | -75.1% | 50,000 | -44.3% | 0.51% | -75.3% |
| Q3 2016 | $5,509,000 | +37.6% | 89,700 | -57.3% | 2.07% | +7.5% |
| Q2 2016 | $4,005,000 | +38.4% | 210,000 | +180.0% | 1.92% | +39.0% |
| Q4 2015 | $2,894,000 | +184.0% | 75,000 | +136.3% | 1.38% | +134.6% |
| Q3 2015 | $1,019,000 | – | 31,744 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,195,000 | $142,432,000 | 6.16% |
| Casdin Capital, LLC | 305,000 | $36,353,000 | 3.99% |
| Eventide Asset Management | 845,168 | $100,736,000 | 3.47% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 436,000 | $51,967,000 | 3.26% |
| NEXTHERA CAPITAL LP | 21,270 | $2,535,000 | 3.08% |
| Camber Capital Management LP | 500,000 | $59,595,000 | 2.97% |
| Eversept Partners, LP | 83,574 | $9,961,185 | 2.91% |
| CADIAN CAPITAL MANAGEMENT, LP | 610,546 | $72,771,000 | 2.84% |
| RTW INVESTMENTS, LP | 338,199 | $40,310,000 | 2.75% |
| Cormorant Asset Management, LP | 300,000 | $35,757,000 | 2.42% |